Neeraj Sood

Oct 14, 2023 | thehill.com | Neeraj Sood |Karen Van Nuys

Most Americans believe drugs cost too much and big pharma is to blame. That powerful political sentiment undergirds Medicare’s new authority to negotiate prices directly with manufacturers. The negotiations may result in lower revenues for pharma but will also imperil future drug development.  There is a better solution: Force transparency into the drug supply chain, unleashing market forces on middlemen whose hidden deals generate excessive profits.

Jul 14, 2023 | statnews.com | Neeraj Sood |Jagpreet Chhatwal

Congress faces a historic opportunity to stamp out a disease that kills thousands of Americans each year and save billions of dollars to boot. In March, the Biden administration proposed an initiative to eliminate hepatitis C in the United States — a plan that should make sense to both conservatives and progressives. With colleagues, we estimated that the initiative will avert 20,000 cases of cancer, 49,100 cases of diabetes, and 25,000 cases of chronic kidney disease over 10 years.